Pristimerin enhances the effect of cisplatin by inhibiting the miR‑23a/Akt/GSK3β signaling pathway and suppressing autophagy in lung cancer cells
Affiliations: Department of Radiation Oncology, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China, Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, College of Life Science, Northwest University, Xi'an, Shaanxi 710069, P.R. China
- Published online on: January 10, 2019 https://doi.org/10.3892/ijmm.2019.4057
- Pages: 1382-1394
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.